Eli M. Soyfer

Eli M. Soyfer

Auto-generated profile, based on publicly available information

Eli M. Soyfer

Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
LLLaura F. Mendez Luque
Laura F. Mendez Luque
JAJulio Avelar-Barragan
Julio Avelar-Barragan
HNHellen Nguyen
Hellen Nguyen
JNJenny Nguyen
Jenny Nguyen
ESEli M. Soyfer
Eli M. Soyfer
AFAngela Fleischman
Angela Fleischman
Purpose: Chronic inflammation is integral to myeloproliferative neoplasm (MPN) pathogenesis. JAK inhibitors reduce cytokine levels, but not without significant side effects. Nutrition is a low-risk approach to reduce inflammation and ameliorate symptoms in MPN. We performed a randomized, parallel-arm study to determine the feasibility of an education-focused Mediterranean diet intervention among patients with MPN. Experimental Design: We randomly assigned patients with MPN to either a Mediterranean diet or standard U.S. Dietary Guidelines for Americans (USDA). Groups received equal but separate education with registered dietician counseling and written dietary resources. Patients were prospectively followed for feasibility, adherence, and symptom burden assessments. Biological samples were collected at four timepoints during the 15-week study to explore changes in inflammatory biomarkers and gut microbiome. Results: The Mediterranean diet was as easy to follow for patients with MPN as the standard USDA diet. Approximately 80% of the patients in the Mediterranean diet group achieved a Mediterranean Diet Adherence Score of ≥8 throughout the entire active intervention period, whereas less than 50% of the USDA group achieved a score of ≥8 at any timepoint. Improvement in symptom burden was observed in both diet groups. No significant changes were observed in inflammatory cytokines. The diversity and composition of the gut microbiome remained stable throughout the duration of the intervention. Conclusions: With dietician counseling and written education, patients with MPN can adhere to a Mediterranean eating pattern. Diet interventions may be further developed as a component of MPN care, and potentially incorporated into the management of other hematologic conditions. Significance: Diet is a central tenant of management of chronic conditions characterized by subclinical inflammation, such as cardiovascular disease, but has not entered the treatment algorithm for clonal hematologic disorders. Here, we establish that a Mediterranean diet intervention is feasible in the MPN patient population and can improve symptom burden. These findings warrant large dietary interventions in patients with hematologic disorders to test the impact of diet on clinical outcomes.

27 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
VRValeria Rangel
Valeria Rangel
JSJason N. Sterrenberg
Jason N. Sterrenberg
AGAya Garawi
Aya Garawi
VMVyanka Mezcord
Vyanka Mezcord
MFMelissa L. Folkerts
Melissa L. Folkerts
NPNick Pannunzio
Nick Pannunzio
Activation-induced cytidine deaminase (AID) is a B cell-specific mutator required for antibody diversification. However, it is also implicated in the etiology of several B cell malignancies. Evaluating the AID-induced mutation load in patients at-risk for certain blood cancers is critical in assessing disease severity and treatment options. We have developed a digital PCR (dPCR) assay that allows us to quantify mutations resulting from AID modification or DNA double-strand break (DSB) formation and repair at sites known to be prone to DSBs. Implementation of this assay shows that increased AID levels in immature B cells increase genome instability at loci linked to chromosomal translocation formation. This includes the CRLF2 locus that is often involved in translocations associated with a subtype of acute lymphoblastic leukemia (ALL) that disproportionately affects Hispanics, particularly those with Latin American ancestry. Using dPCR, we characterize the CRLF2 locus in B cell-derived genomic DNA from both Hispanic ALL patients and healthy Hispanic donors and found increased mutations in both, suggesting that vulnerability to DNA damage at CRLF2 may be driving this health disparity. Our ability to detect and quantify these mutations will potentiate future risk identification, early detection of cancers, and reduction of associated cancer health disparities.

12 April 2024 in Blood Neoplasia
Verified
Journal Article
Open access
ESEli M. Soyfer
Eli M. Soyfer
JHJianhong C. Heidmann
Jianhong C. Heidmann
GRGajalakshmi Ramanathan
Gajalakshmi Ramanathan
HNHellen Nguyen
Hellen Nguyen
SBSimran Bhardwaj
Simran Bhardwaj
AFAngela Fleischman
Angela Fleischman

5 March 2024
Verified
Other
Open access
LLLaura F. Mendez Luque
Laura F. Mendez Luque
JAJulio Avelar-Barragan
Julio Avelar-Barragan
HNHellen Nguyen
Hellen Nguyen
JNJenny Nguyen
Jenny Nguyen
ESEli M. Soyfer
Eli M. Soyfer
AFAngela Fleischman
Angela Fleischman
Baseline and week 9 BMI. Baseline BMI was calculated using height and weight at enrollment, with no significant differences between USDA and MED groups. Weight was followed throughout the study, no significant changes in BMI were observed in either group.

5 March 2024
Verified
Other
Open access
PDF file
LLLaura F. Mendez Luque
Laura F. Mendez Luque
JAJulio Avelar-Barragan
Julio Avelar-Barragan
HNHellen Nguyen
Hellen Nguyen
JNJenny Nguyen
Jenny Nguyen
ESEli M. Soyfer
Eli M. Soyfer
AFAngela Fleischman
Angela Fleischman
Supplementary Table 2. Representativeness of Study Participants.

5 March 2024
Verified
Other
Open access
LLLaura F. Mendez Luque
Laura F. Mendez Luque
JAJulio Avelar-Barragan
Julio Avelar-Barragan
HNHellen Nguyen
Hellen Nguyen
JNJenny Nguyen
Jenny Nguyen
ESEli M. Soyfer
Eli M. Soyfer
AFAngela Fleischman
Angela Fleischman
Baseline and week 9 BMI. Baseline BMI was calculated using height and weight at enrollment, with no significant differences between USDA and MED groups. Weight was followed throughout the study, no significant changes in BMI were observed in either group.